Placebo often effective for treating headache in children

Placebo often effective for treating headache in children
Placebo is often effective in treating children with headaches, and innovative strategies are needed to reduce the placebo response rate and prove drug effects in trials, according to two studies published online Jan. 28 in JAMA Pediatrics.

(HealthDay)—Placebo is often effective in treating children with headaches, and innovative strategies are needed to reduce the placebo response rate and prove drug effects in trials, according to two studies published online Jan. 28 in JAMA Pediatrics.

In the first study, Khalil El-Chammas, M.D., from the Medical College of Wisconsin in Milwaukee, and colleagues performed a meta-analysis of 21 assessing prophylactic headache treatment to reduce the frequency or severity of headaches in children and adolescents. The researchers found that placebos were effective, while drugs, including topiramate and trazodone, showed some efficacy for episodic migraines. Other commonly used drugs were no more effective than placebo.

In the second study, Haihao Sun, M.D., Ph.D., from the U.S. in Silver Spring, Md., and colleagues performed a systematic review and analysis of pediatric trial data submitted to the FDA on triptans, already approved for adults but which had failed to show efficacy for treatment of abortive migraines in children. The researchers observed a high placebo response, with at two hours ranging from 53.0 to 57.5 percent, which could be reduced by non-randomization of patients with an early placebo response.

"Innovative trial designs intended to reduce the rate may be necessary to demonstrate a drug effect," Sun and colleagues write.

More information: Abstract - El-Chammas
Full Text (subscription or payment may be required)
Abstract - Sun
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

No proof drugs ease kids' migraines, study says

Jan 28, 2013

(HealthDay)—Children and teens who get migraine headaches suffer in multiple ways, missing school and fun time with friends while waiting for the debilitating pain to subside.

Greater response to placebo in children than in adults

Aug 12, 2008

In a systematic review of antiepileptic drugs, Philippe Ryvlin (of the Hospices Civils de Lyon, France) and colleagues show that children with drug-resistant partial epilepsy enrolled in trials seem to have a greater response ...

Recommended for you

Want kids to eat better? Get them cooking

22 hours ago

(HealthDay)—Getting kids involved in the kitchen, through cooking classes or at home, may make them more likely to choose healthy foods, according to a recent review.

Life-saving promise in simple steps

Nov 27, 2014

The debate over the best time to clamp a baby's umbilical cord has been around forever. In about 350 BCE, Aristotle, reputedly the world's first genuine scientist, advocated delaying clamping until placenta ...

PCV13 recommended for 6- to 18-year-olds at high risk

Nov 26, 2014

(HealthDay)—Pneumococcal conjugate vaccine 13 (PCV13) should be administered to certain children aged 6 through 18 years who are at high risk of invasive pneumococcal disease (IPD), according to a policy ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.